Dear Dr. Hampshire,
"On behalf of the 90 undersigned organizations representing a wide range of biomedical professional societies, institutions, and individual researchers, we commend the Department of Transportation’s (DOT) decision to appoint a Chief Science Officer. Science plays an integral role in operating, maintaining, and enabling a robust infrastructure system that enhances the American economy and our quality of life. Accordingly, we strongly encourage the Chief Science Officer to review the 2018 docket complaint (Docket No. DOT-OST-2018-0124, NABR v. United Airlines et al) regarding the refusal of certain airlines to transport animals for research purposes. This unresolved complaint continues to jeopardize essential biomedical research by inhibiting access to the appropriate animal models necessary for addressing the nation’s pressing scientific and public health questions. As part of the Administration’s efforts to elevate science in the policy-making process, we encourage DOT to review this complaint and ensure that airline policies do not arbitrarily exclude transport of animals required for life-saving biomedical research, including drug testing required by law."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.